AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1

Historical Holders from Q3 2015 to Q3 2019

Type / Class
Debt / NOTE 2.000% 8/1
All holders as of 30 Sep 2019
Q3 2019
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1

Period Principal Value Change Price Investors
2019 Q3 0 $0 -$36,674,000 0
2019 Q2 52,392,000 $36,674,000 -$158,977,000 $0.7 1
2019 Q1 275,922,000 $195,651,000 -$21,007,000 $0.6825 11
2018 Q4 301,922,000 $235,262,000 -$17,055,998 $0.7582 12
2018 Q3 325,922,000 $242,637,000 +$3,107,009 $0.7499 13
2018 Q2 322,922,000 $215,930,000 -$861,107 $0.6489 15
2018 Q1 323,422,000 $252,271,000 -$1,339,655 $0.7734 14
2017 Q4 324,980,000 $261,810,000 +$1,199,224 $0.7957 16
2017 Q3 228,435,000 $183,797,000 +$1,680,496 $0.7972 16
2017 Q2 226,483,400 $183,384,428 +$3,384,778 $0.8082 20
2017 Q1 222,654,000 $185,699,000 -$5,693,713 $0.8086 19
2016 Q4 231,931,000 $166,359,350 +$956,365 $0.7143 18
2016 Q3 231,147,000 $153,251,085 -$12,197,203 $0.66 19
2016 Q2 253,996,000 $144,127,000 +$2,153,827 $0.57 24
2016 Q1 251,498,500 $130,172,034 -$15,804,882 $0.5082 24
2015 Q4 344,442,500 $228,110,379 +$1,251,721 $0.664 30
2015 Q3 291,967,500 $220,710,621 +$196,009,621 $0.753 29